{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:41:00Z","timestamp":1775932860331,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":47,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd011033.pub2","type":"reference-entry","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T13:47:05Z","timestamp":1454334425000},"source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological treatment for Buerger's disease"],"prefix":"10.1002","author":[{"given":"Daniel G","family":"Cacione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose CC","family":"Baptista-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane R","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"10.1002\/14651858.CD011033.pub2-BIB1|cit1","first-page":"1034","article-title":"The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (thromboangiitis obliterans)","volume":"19","author":"Beigi","year":"2014","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD011033.pub2-BIB2|cit2","first-page":"2111","article-title":"Studies on the clinical efficacy and safety of TTC-909 in the treatment of peripheral arterial occlusive disease: a multi-center double-blind comparison with Alprostadil incorporated in lipid microspheres","volume":"11","author":"Esato","year":"1995","journal-title":"Rinsho Iyaku"},{"key":"10.1002\/14651858.CD011033.pub2-BIB3|cit3","first-page":"178","article-title":"Multicenter-study on Iloprost in patients with thromboangiitis obliterans (Buerger's disease)","volume":"67","author":"Diehm","year":"1989","journal-title":"Klinische Wochenschrift"},{"issue":"8689","key":"10.1002\/14651858.CD011033.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","article-title":"Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans","volume":"335","author":"Fiessinger","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011033.pub2-BIB5|cit5","first-page":"1836","article-title":"Therapeutic efficacy of iloprost, a prostacyclin analogue for chronic arterial occlusion: a double-blind comparative study with PGE1","volume":"68","author":"Ishitobi","year":"1991","journal-title":"Rinsho to Kenkyu"},{"issue":"4","key":"10.1002\/14651858.CD011033.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1078-5884(98)80032-4","article-title":"Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): A double-blind, randomised, placebo-controlled trial. The European TAO Study Group","volume":"15","author":"Verstraete","year":"1998","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD011033.pub2-BIB7|cit7","first-page":"162","article-title":"A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease","volume":"25","author":"Bozkurt","year":"2006","journal-title":"International Angiology"},{"issue":"9","key":"10.1002\/14651858.CD011033.pub2-BIB8|cit8","first-page":"497","article-title":"Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study","volume":"20","author":"Coscia","year":"1972","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD011033.pub2-BIB9|cit9","first-page":"76","article-title":"The application of Simiaoyongantangjiawei in the treatment of thromboangiitis obliterans","volume":"14","author":"He","year":"2007","journal-title":"Chinese Journal of Information on Traditional Chinese Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0090-6980(86)90225-X","article-title":"Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease","volume":"31","author":"Musial","year":"1986","journal-title":"Prostaglandins"},{"key":"10.1002\/14651858.CD011033.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cpt1975175612","article-title":"Controlled trial of propranolol in intermittent claudication","volume":"17","author":"Reichert","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011033.pub2-BIB12|cit12","first-page":"2025","article-title":"Report on the clinical testing of Lamuran (I)","volume":"35","author":"Steinorth","year":"1967","journal-title":"Die Medizinische Welt"},{"issue":"10","key":"10.1002\/14651858.CD011033.pub2-BIB13|cit13","article-title":"Point injection of prostaglandin E1 on Sanyinjiao Acupuncture (SP6) for thromboangiitis obliterans pain in 24 cases","volume":"13","author":"Sun","year":"1993","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi [Chinese Journal of Integrated Traditional and Western Medicine]"},{"key":"10.1002\/14651858.CD011033.pub2-BIB14|cit14","first-page":"73","article-title":"Clinical study of treating thromboangitis obliterans with overlapping thinning chisel therapy","volume":"12","author":"Yang","year":"2005","journal-title":"Chinese Journal of Information on TCM"},{"key":"10.1002\/14651858.CD011033.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1536\/ihj.14.12","article-title":"A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries","volume":"14","author":"Zelikovsky","year":"1973","journal-title":"Japanese Heart Journal"},{"key":"10.1002\/14651858.CD011033.pub2-BIB16|cit16","first-page":"3409","article-title":"Results of dose finding study of Pamicogrel (KBT-3022) on chronic arterial occlusive diseases","volume":"13","author":"Hoshino","year":"1997","journal-title":"Rinsho Iyaku"},{"issue":"7454","key":"10.1002\/14651858.CD011033.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB18|cit18","first-page":"82","article-title":"Buerger's disease: etiologic role of the rickettsiae?","volume":"12","author":"Bartolo","year":"1987","journal-title":"Journal des Maladies Vasculaires"},{"issue":"10","key":"10.1002\/14651858.CD011033.pub2-BIB19|cit19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub4","article-title":"Cilostazol for intermittent claudication","author":"Bedenis","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011033.pub2-BIB20|cit20","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"key":"10.1002\/14651858.CD011033.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000441-190810000-00011","article-title":"Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene","volume":"136","author":"Buerger","year":"1908","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD011033.pub2-BIB22|cit22","first-page":"31","article-title":"Epidemiology and geographic distribution of the thromboangiitis obliterans","volume-title":"Thromboangiitis obliterans Morbus Winiwarter-Buerger","author":"Cachovan","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD011033.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00129784-200303020-00006","article-title":"Cilostazol: a review of its use in intermittent claudication","volume":"3","author":"Chapman","year":"2003","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"12","key":"10.1002\/14651858.CD011033.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jacc.2004.09.029","article-title":"Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)","volume":"44","author":"Cooper","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011033.pub2-BIB25|cit25","doi-asserted-by":"crossref","unstructured":"De Haro J Florez A Fernadez JL Acin F Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report BMJ Case Reports 2009","DOI":"10.1136\/bcr.08.2008.0691"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/157489009787260025","article-title":"A review of cilostazol, a phosphodiesterase inhibitor, and its role in preventing both coronary and peripheral arterial restenosis following endovascular therapy","volume":"4","author":"Dindyal","year":"2009","journal-title":"Recent Patents on Cardiovascular Drug Discovery"},{"issue":"5","key":"10.1002\/14651858.CD011033.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1708538113491256","article-title":"Is rickettsia the key to solving the puzzle of Buerger\u2019s disease?","volume":"22","author":"Fazeli","year":"2013","journal-title":"Vascular"},{"key":"10.1002\/14651858.CD011033.pub2-BIB28|cit28","unstructured":"US Food Drug Administration FDA approved drug products http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search. DrugDetails (accessed 25 November 2015)"},{"issue":"5\/6","key":"10.1002\/14651858.CD011033.pub2-BIB29|cit29","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helvetica Chirurgica Acta"},{"issue":"6","key":"10.1002\/14651858.CD011033.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199243060-00008","article-title":"Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures","volume":"43","author":"Grant","year":"1992","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD011033.pub2-BIB31|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jvs.2005.03.016","article-title":"Oral bacteria in the occluded arteries of patients with Buerger disease","volume":"42","author":"Iwai","year":"2005","journal-title":"Journal of Vascular Surgery"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD011033.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0755-4982(06)74645-0","article-title":"Bosentan for treatment of active digital ulcers in patients with systemic sclerosis","volume":"35","author":"Launay","year":"2006","journal-title":"La Presse M\u00e9dicale"},{"issue":"6","key":"10.1002\/14651858.CD011033.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.thromres.2008.03.011","article-title":"An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation","volume":"122","author":"Li","year":"2008","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD011033.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2009.01.042","article-title":"Thromboangiitis obliterans in the 21st century - a new face of disease","volume":"206","author":"Malecki","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011033.pub2-BIB37|cit37","first-page":"219","article-title":"Critical limb ischemia: definition and natural history","volume":"4","author":"Novo","year":"2004","journal-title":"Current Drug Targets"},{"issue":"12","key":"10.1002\/14651858.CD011033.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger's disease)","volume":"343","author":"Olin","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.bor.0000198000.58073.aa","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"18","author":"Olin","year":"2006","journal-title":"Current Opinion in Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD011033.pub2-BIB40|cit40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006544.pub2","article-title":"Prostanoids for critical limb ischaemia","author":"Ruffolo","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011033.pub2-BIB41|cit41","volume-title":"Vascular Surgery","volume":"1","author":"Rutherford","year":"2005"},{"issue":"6","key":"10.1002\/14651858.CD011033.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.rmed.2010.12.018","article-title":"Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs","volume":"105","author":"Safdar","year":"2011","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011033.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF01655948","article-title":"What is Buerger's disease?","volume":"7","author":"Shionoya","year":"1983","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD011033.pub2-BIB44|cit44","first-page":"202","article-title":"A peculiar form of endarteritis and endophlebitis with gangrene of the foot","volume":"23","author":"Winiwarter","year":"1879","journal-title":"Archiv f\u00fcr Klinische Chirurgie"},{"key":"10.1002\/14651858.CD011033.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0009-9236(96)90127-7","article-title":"Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentanin healthy human subjects","volume":"60","author":"Weber","year":"1996","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011033.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.111.060335","article-title":"Nonatherosclerotic arterial disorders of the lower extremities","volume":"126","author":"Weinberg","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD011033.pub2-BIB47|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011033","article-title":"Pharmacological treatment for Buerger's disease","author":"Cacione","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011033.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011033.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:51:41Z","timestamp":1628549501000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011033.pub2"}},"subtitle":[],"editor":[{"given":"Daniel G","family":"Cacione","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011033.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD011033.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2016,2,1]]}}}